TEMITOPE OLUMUJI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health RICHMOND, TX NPI 1760119952
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health TX Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$2,534.05
- Category: General Payments
- Program years: PY2022–2024
- Record count: 92
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $332.83 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.83 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $154.00 | 3 |
| ABBVIE INC. | $138.38 | 2 |
| Neurocrine BioSciences, Inc. | $27.34 | 1 |
| Axsome Therapeutics, Inc. | $13.11 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1107763716 | ABBVIE INC. | $120.27 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1107763718 | ABBVIE INC. | $18.11 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119154219 | Otsuka America Pharmaceutical, Inc. | $9.78 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119154221 | Otsuka America Pharmaceutical, Inc. | $123.24 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119154223 | Otsuka America Pharmaceutical, Inc. | $20.98 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148414988 | Axsome Therapeutics, Inc. | $13.11 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150946855 | Neurocrine Biosciences, Inc. | $27.34 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.